Global Fertility Testing Devices Market is Poised to Reach USD 216.8 Million by 2020

Date: 2016-05-09

The global fertility testing devices market is poised to reach USD 216.8 million by 2020 at a CAGR of 7.5% during the forecast period. The market for fertility testing devices is expected to witness high growth in the Asia-Pacific region. Factors such as decreasing fertility rate, growing number of women suffering from lifestyle disorders, rising funding/investments for the development of fertility and ovulation monitors, and growing focus of both international and domestic players on the Asia-Pacific fertility testing devices market are driving the growth of the market in this region.

Geographically, North America commanded the largest share of the global fertility testing devices market in 2015, followed by Europe. A number of factors such as decline in fertility rate owing to the rising first-time pregnancy age and high prevalence of PCOS (polycystic ovary syndrome) among North American women, increasing awareness about the benefits offered by ovulation monitors and fertility awareness methods (FAM) in successful conception among women, and the development of advanced low-cost devices are expected to support market growth in North America. However, stringent regulatory policies for the approval of medical devices, increasing government pressure to reduce healthcare costs, and rising adoption of low-cost ovulation monitors (resulting in lower revenue growth) are restraining the growth of the fertility testing devices market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of the global fertility testing devices market in the next five years.

The global fertility testing devices market is highly competitive, with a large number of small market players. As of 2014, the global fertility testing devices market was dominated by SPD Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.), which accounted for a market share of more than 50% in 2014. Other players in this market include Geratherm Medical AG (Germany), HiLin Life Products, Inc. (U.S.), Fairhaven Health, LLC (U.S.), and Fertility Focus Limited (U.K.). New product development, partnerships, agreements, and collaboration are the major strategies adopted by most of the players to achieve growth in the fertility testing devices market.

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample